Antenatal Reproductive Screening for Pregnant People including Preconception: Provides the Best Reproductive Opportunity for Informed Consent, Quality, and …
RD Wilson - Best Practice & Research Clinical Obstetrics & …, 2024 - Elsevier
Introduction This antenatal screening review will include reproductive screening evidence
and approaches for pre-conception and post-conception, using first to third trimester …
and approaches for pre-conception and post-conception, using first to third trimester …
[HTML][HTML] Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological …
V Giudice, M Ianniello, D De Novellis… - Clinical and …, 2024 - Springer
Liquid biopsy is a minimally invasive diagnostic tool for identification of tumor-related
mutations in circulating cell-free DNA (cfDNA). The aim of this study was to investigate …
mutations in circulating cell-free DNA (cfDNA). The aim of this study was to investigate …
[HTML][HTML] Prenatal Genome-Wide Cell-Free DNA Screening: Three Years of Clinical Experience in a Hospital Prenatal Diagnostic Unit in Spain
L Pedrola Vidal, M Roselló Piera, C Martín-Grau… - Genes, 2024 - mdpi.com
Genome-wide prenatal cell-free DNA (cfDNA) screening can be used to screen for a wide
range of fetal chromosomal anomalies in pregnant patients. In this study, we describe our …
range of fetal chromosomal anomalies in pregnant patients. In this study, we describe our …